This is not the most recent version of the article. View current version (16 MAR 2011)

Intervention Review

Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion

  1. David A Henry1,*,
  2. Paul A Carless2,
  3. Annette J Moxey2,
  4. Dianne O'Connell3,
  5. Barrie J Stokes2,
  6. Brian McClelland4,
  7. Andreas Laupacis5,
  8. Dean A Fergusson6

Editorial Group: Cochrane Injuries Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 9 JUL 2007

DOI: 10.1002/14651858.CD001886.pub2

Database Title

Additional Information

How to Cite

Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, McClelland B, Laupacis A, Fergusson DA. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD001886. DOI: 10.1002/14651858.CD001886.pub2.

Author Information

  1. 1

    Institute of Clinical Evaluative Sciences, Toronto, Ontario, Canada

  2. 2

    Faculty of Health, University of Newcastle, Discipline of Clinical Pharmacology, Newcastle, New South Wales, Australia

  3. 3

    The Cancer Council NSW, Cancer Epidemiology Research Unit, Sydney, NSW, Australia

  4. 4

    Scottish National Blood Transfusion Service, Edinburgh, UK

  5. 5

    Li Ka Shing Knowledge Institute of St. Michael's Hospital , Department of Medicine, Toronto, Ontario, Canada

  6. 6

    University of Ottawa Centre for Transfusion Research, Ottawa Health Research Institute, Ottawa, Ontario, Canada

*David A Henry, Institute of Clinical Evaluative Sciences, 2075 Bayview Avenue, G1 06, Toronto, Ontario, M4N 3M5, Canada. david.henry@ices.on.ca.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

ARTICLE TOOLS

This is not the most recent version of the article.View current version (16 Mar 2011)

View Full Article (HTML) Summary (63K)Standard (1537K)Full (2526K)

  1. Current Version

    Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion

    David A Henry, Paul A Carless, Annette J Moxey, Dianne O'Connell, Barrie J Stokes, Dean A Fergusson and Katharine Ker

    Article first published online: 16 MAR 2011 | DOI: 10.1002/14651858.CD001886.pub4

Previous versions of this article and their online publication dates

  1. Version 3

    Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion

    David A Henry, Paul A Carless, Annette J Moxey, Dianne O'Connell, Barrie J Stokes, Dean A Fergusson and Katharine Ker

    Article first published online: 19 JAN 2011 | DOI: 10.1002/14651858.CD001886.pub3

  2. Version 2

    Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion

    David A Henry, Paul A Carless, Annette J Moxey, Dianne O'Connell, Barrie J Stokes, Brian McClelland, Andreas Laupacis and Dean A Fergusson

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD001886.pub2

  3. Version 1

    Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion

    DA Henry, AJ Moxey, PA Carless, D O'Connell, B McClelland, KM Henderson, K Sly, A Laupacis and D Fergusson

    Article first published online: 18 JUL 2007 | DOI: 10.1002/14651858.CD001886

View Full Article (HTML) Summary (63K)Standard (1537K)Full (2526K)